PRGO Q2 2025 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q2 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B-0.9% YoY

Gross Profit

$363M34.4% margin

Operating Income

$45M4.3% margin

Net Income

-$8M-0.8% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+1.2%

Cash Flow

Operating Cash Flow

$76M

Free Cash Flow

$57M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$10.1B

Total Liabilities

$5.6B

Stockholders' Equity

$4.5B

Cash & Equivalents

$454M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.1B	-0.9%
Gross Profit	$363M	$395M	-8.1%
Operating Income	$45M	-$27M	+271.3%
Net Income	-$8M	-$108M	+92.3%

Revenue Segments

Consumer Self-Care Americas

$622M59%

Consumer Self-Care International

$434M41%

Geographic Segments

UNITED STATES

$611M57%

Europe

$422M40%

Other Geographical Areas

$24M2%

IRELAND

$10M1%